Masimo Corporation (MASI) Releases Earnings Results, Beats Expectations By $0.16 EPS

Masimo Corporation (MASI) reported quarterly earnings results on Wednesday, Aug-3-2016. The company said it had a profit of $0.57 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.16. Analysts had a consensus of $0.41. The company posted revenue of $172.64 million in the period, compared to analysts expectations of $166.03 million. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.

Masimo Corporation closed down -0.39 points or -0.74% at $52.54 with 2,25,086 shares getting traded on Tusday. Post opening the session at $53.16, the shares hit an intraday low of $52.44 and an intraday high of $53.16 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.

In a different news, on Jul 1, 2016, Ramshorst David J Van (Chief Accounting Officer) sold 5,000 shares at $52.50 per share price. According to the SEC, on Jun 8, 2016, Joe E Kiani (CEO and Chairman of the Board) sold 65,048 shares at $50.00 per share price. On Jun 2, 2016, Jon Coleman (Pres-WW Sales,Pro Svc,Med Affs) sold 4,000 shares at $50.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Masimo Corporation is a global medical technology company that develops manufactures and markets non-invasive patient monitoring products. The Company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring optical organ oximetry monitoring electrical brain function monitoring acoustic respiration monitoring and optical gas monitoring. In addition the Company offers Root patient monitoring and connectivity platform the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Masimo Corporation

Leave a Reply

Masimo Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Masimo Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.